DMN:FRA
Diamyd Medical AB
€0.063
0.00%
(0.00) 1 天
11月19日, GMT+1 22:00:00 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 DMN 生成关键数据洞见…
开盘价
€0.06
最高价
€0.06
最低价
€0.06
市值
1.42亿
平均成交量
0.00
成交量
0.00
52 周最高价
€1.80
52 周最低价
€0.05
员工人数
42
开盘价
€0.06
最高价
€0.06
最低价
€0.06
市值
1.42亿
平均成交量
0.00
成交量
0.00
52 周最高价
€1.80
52 周最低价
€0.05
员工人数
42
新闻报道
来自网络来源和新闻合作伙伴
Traders Union
·
32分钟前
Gunjan Banerji: Only 38 S&P 500 stocks rose, fewest gainers since December 31, 2025
The Motley Fool
·
17分钟前
Stock Market Today, Nov. 19: Dow Plunges 1,100 Points as the S&P 500 Suffers Its 6th Straight Day of Losses
Investing.com
·
28分钟前
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.19%
资料
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
Diamyd Medical AB简介